Biography

Prof. Nejat Akar

Department of Pediatrics
TOBB-Economy Technical University Hospital, Turkey


Email: akar@medicine.ankara.edu.tr


Qualifications

1995  Pediatrics Department of Ankara University, Turkey
1977  Ankara University, Medical School, Turkey


Publications(Selected)

  1. Yalçinkaya F, Ozçakar ZB, Kasapçopur O, Oztürk A, Akar N, Bakkaloğlu A, Arisoy N, Ekim M, Ozen S. Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa.J Pediatr. 2007;151(6): 675-8.
  2. Eyileten Z, Akar AR, Sirlak M, Ucanok K, Akar N. Off-pump coronary artery bypass graft surgery after stent implantation in a patient with combined thrombophilic risk factors. Can J Cardiol. 2007;23(13): 1083-4.
  3. Akar N, Donmez B, Deda G.FXIII gene Val34Leu polymorphism in Turkish children with cerebral infarct. J Child Neurol. 2007;22(2): 222-4.
  4. Kendirli T, Ciftci E, Ince E, Yurdakul E, Kansu A, Akar N.Homozygous 23-bp insertion of endothelial protein c receptor gene in a child with fatal sepsis. Pediatr Hematol Oncol. 2007;24(3): 199-204.
  5. Ulukol B, Orhon FS, Hanoluk A, Akar N.Serum pro-hepcidin levels and relationship with ferritin in healthy non-anaemic infants. Acta Haematol. 2007;118(2): 70-2.
  6. Tekin M, Hismi BO, Fitoz S, Ozdag H, Cengiz FB, Sirmaci A, Aslan I, Inceoglu B, Yuksel-Konuk EB, Yilmaz ST, Yasun O, Akar N. Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia. Am J Hum Genet. 2007;80(2): 338-44.
  7. Eroglu A, Ulu A, Cam R, Kurtman C, Akar N.Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.J Thromb Thrombolysis. 2007;23(1): 31-4.
  8. Akar N. A further note on thrombosis in patients with homozygous beta thalassemia. Thromb Haemost. 2007;97(1): 167.
  9. Ulu A.Deda G.,Eğin Y, Traş S., Akar N.EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients. Thromb Res. 2007;120(1): 47-52.
  10. Akar N. Idiopathic portal vein thrombosis and FVIII levels. Thromb Res. 2007;120(1): 141.
  11. Eroglu A, Gulec S, Akar N. Vascular endothelial growth factor C936T polymorphism in cancer patients with thrombosis. Am J Hematol. 2007; 82(2): 174.
  12. Akar N, Reisman A, Oral A.Albert Eckstein (1891-1950): modernizer of Turkey's paediatrics in exile. J Med Biogr. 2007 Nov; 15(4): 213-8.
  13. Ozdag H, Egin Y, Akar N.Prothrombin gene 20209 C >T along with the first description of a homozygous polymorphism at the 3' downstream region +4 C >T in the Turkish population.Lab Hematol. 2006; 12(3): 131-3.
  14. Eroglu A, Gulec S, Akar N.Vascular endothelial growth factor C936T polymorphism in cancer patients with thrombosis. Am J Hematol. 2007 Feb; 82(2): 174.
  15. Akar N, Hasipek M, Ozturk A, Akar E, Tekin M.Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. J Nephrol. 2006 May-Jun; 19(3): 318-21.
  16. Berber E, Fidanci ID, Un C, El-Maarri O, Aktuglu G, Gurgey A, Celkan T, Meral A, Oldenburg J, Graw J, Akar N, Caglayan H.Sequencing of the factor 8(F8) coding regions in 10 Turkish hemophilia A patients reveals three novel pathological mutations, and one rediagnosis of von Willebrand's disease type 2N. Haemophilia. 2006 Jul; 12(4): 398-400.
  17. Berberoglu M, Evliyaoglu O, Adiyaman P, Ocal G, Ulukol B, Simsek F, Siklar Z, Torel A, Ozel D, Akar N.Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children. J Pediatr Endocrinol Metab. 2006 May; 19(5): 741-8.
  18. Tekin M, Hismi BO, Fitoz S, Yalcinkaya F, Ekim M, Kansu A, Ertem M, Deda G, Tutar E, Arsan S, Zhou XP, Pilarski R, Eng C, Akar N.A germline PTEN mutation with manifestations of prenatal onset and verrucous epidermal nevus. Am J Med Genet A. 2006 1; 140(13): 1472-5.
  19. Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, Rohde K, Schulz HU, Le Marechal C, Akar N, Ammann RW, Truninger K, Bargetzi M, Bhatia E, Castellani C, Cavestro GM, Cerny M, Destro-Bisol G, Spedini G, Eiberg H, Jansen JB, Koudova M, Rausova E, Macek M Jr, Malats N, Real FX, Menzel HJ, Moral P, Galavotti R, Pignatti PF, Rickards O, Spicak J, Zarnescu NO, Bock W, Gress TM, Friess H, Ockenga J, Schmidt H, Pfutzer R, Lohr M, Simon P, Weiss FU, Lerch MM, Teich N, Keim V, Berg T, Wiedenmann B, Luck W, Groneberg DA, Becker M, Keil T, Kage A, Bernardova J, Braun M, Guldner C, Halangk J, Rosendahl J, Witt U, Treiber M, Nickel R, Ferec C.A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006 Jun; 38(6): 668-73
  20. Akar N, Ozturk A, Ozel D, Akar E, Ekim M.Is MEFV P706 polymorphism important in familial Mediterranean fever patients? J Nephrol. 2006 Jan-Feb; 19(1): 119-20.
  21. Akar N, Noma, LANCET 368 (9540): 989-989 2006
  22. Eroglu A, Gulec S, Kurtman C, Akar N. Vascular endothelial growth factor 936 C/T polymorphism in cancer patients ANNALS OF ONCOLOGY 17 (9): 1467-U4 2006
  23. Akar N, Akar E, Arac B, Ulu A.Does SLC30A4 (ZNT4) gene exon 5 915 T-C alteration play a role in neural tube defects? TRACE ELEMENTS AND ELECTROLYTES 23 (4): 266-269 2006
  24. Ekmekci Y, Keven K, Akar N, et al.Thrombophilia and avascular necrosis of femoral head in kidney allograft recipients NEPHROLOGY DIALYSIS TRANSPLANTATION 21 (12): 3555-3558 2006
  25. Eroglu A, Ulu A, Kurtman C, Cam R, Akar N.23-bp endothelial protein C receptor (EPCR) gene insertion mutation in cancer patients with and without thrombosis.Am J Hematol. 2006 Mar;81(3): 220.
  26. Akar N.A case of thrombosis: possible sickle cell? Thromb Haemost. 2006 Feb;95(2):394;
  27. Arisoy M, Aysev D, Ekim M, Ozel D, Kose SK, Ozsoy ED, Akar N.Detection of virulence factors of Escherichia coli from children by multiplex polymerase chain reaction. Int J Clin Pract. 2006 Feb;60(2): 170-3.
  28. Sipahi T, Pocan H, Akar N.Effect of various genetic polymorphisms on the incidence and outcome of severe sepsis.Clin Appl Thromb Hemost. 2006 Jan; 12(1): 47-54.
  29. Erkekol FO, Ulu A, Numanoglu N, Akar N.High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism. Respirology. 2006 Jan; 11(1): 70-4.
  30. Karahan ZC, Mumcuoglu I, Guriz H, Tamer D, Balaban N, Aysev D, Akar N. P CR evaluation of false-positive signals from two automated blood-culture systems. J Med Microbiol. 2006 Jan; 55(Pt 1): 53-7.
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top